Brannagan TH, Weimer LH (2010). Acquired neuropathies. In LP Rowland, TA Pedley, eds., Merritt's Neurology, 12th ed., pp. 822–837. Philadelphia: Lippincott Williams and Wilkins.
Cortese I, et al. (2011). Evidence-based guideline update: Plasmapheresis in neurologic disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 76(3): 294–300.
Hughes RAC, et al. (2003, reaffirmed 2008). Practice parameter:
Immunotherapy for Guillain-Barré syndrome. Neurology,
Hughes RAC, et al. (2012). Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews (7).
Patwa HW, et al. (2012). Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders. Neurology, 78(13): 1009–1015.
Raphaël JC (2012). Plasma exchange for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews (7).
Ropper AH, Samuels MA (2009). Diseases of the peripheral nerves. In Adams and Victor's Principles of Neurology, 9th ed., pp. 1251–1325. New York: McGraw-Hill.
In this article
This information is produced and provided by the National
Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National
Institute via the Internet web site at http://
.gov or call 1-800-4-CANCER.
WebMD Medical Reference from Healthwise
March 12, 2014
This information is not intended to replace the advice of a doctor.
Healthwise disclaims any liability for the decisions you make based on this